Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice

Xinzhi Li1, Ying Yang1, Zhenzhi Li1

  • 1HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.

Diabetologia
|March 15, 2023
PubMed
Abstract

Insights

Wilms

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Epigenetics

Background:

  • N6-methyladenosine (m6A) mRNA methylation regulates islet beta cell function and diabetes pathogenesis.
  • Key m6A regulators like METTL3, METTL14, and YTHDC1 are implicated, but the role of WTAP remains unclear.

Purpose of the Study:

  • To investigate the role of Wilms' tumour 1-associating protein (WTAP) in islet beta cell failure and diabetes.
  • To elucidate the mechanism by which WTAP influences beta cell function in the context of diabetes.

Main Methods:

  • Generated islet beta cell-specific Wtap-knockout and Mettl3-overexpressing mouse models.
  • Assessed glucose homeostasis, insulin secretion, and beta cell apoptosis.
  • Utilized RNA-sequencing (RNA-seq) and m6A RNA immunoprecipitation sequencing (MeRIP-seq) for comprehensive analysis.

Main Results:

  • WTAP was downregulated in type 2 diabetes islet beta cells, linked to lipotoxicity and inflammation.
  • Deletion of WTAP in beta cells (Wtap-betaKO) led to severe hyperglycemia and beta cell failure.
  • WTAP deficiency reduced m6A modification, decreased key beta cell transcription factors, and impaired insulin secretion via METTL3 downregulation.

Conclusions:

  • WTAP is crucial for maintaining beta cell function through METTL3-dependent m6A modification.
  • Downregulation of WTAP contributes to beta cell failure and the development of diabetes.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.1K